UNSPSC 51172141: Pramiverin or pramiverine

This classification denotes an antispasmotic agent with the molecular formula C21H27N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 157NY06G9T, chemically known as 4,4-diphenyl-n-isopropylcyclohexylamine but generally known as pramiverin, which bears US NIH Compound Identifier 71681. European Medicines Agency schedules Pramiverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09992MIG.

The term PRAMIVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, No. 10 1969, List 9). Pramiverin or pramiverine bears US NLM identifiers UMLS ID C0663384 and NCI Concept Code C73175. SMILES: CC(C)NC1CCC(CC1)(C2=CC=CC=C2)C3=CC=CC=C3.

UNSPSC 51172141 Pramiverin or pramiverine is a Commodity code that in practice captures drug testing services for criminal justice populations, specifically the collection, screening, and confirmation of drug specimens for offender monitoring programs. State and local criminal justice agencies — primarily county community supervision and corrections departments — procure these services to support pretrial, probation, and parole populations. The scope includes specimen collection at dedicated sites, immunoassay screening with confirmatory testing by LC/MS/MS or GC/MS, alternative testing methodologies (oral fluid, hair), electronic result reporting, and the operation of automated randomized-notification systems. Vendors must maintain laboratory certification from SAMHSA, Texas DPS, or CAP and quote on a per-test basis with three service-delivery models: screening only, screening with confirmation, or screening with automatic confirmation of positives. Pricing must be all-inclusive — covering staffing, delivery, insurance, and freight with no surcharges — and subject to price-redetermination caps tied to medical CPI on anniversary dates.

Collin County Community Supervision and Corrections Department posted RFP 2026-327 on September 25, 2026, for offender specimen collection and drug testing services with an estimated annual contract value of $600,000 and a two-year base term plus three optional one-year renewals through September 1, 2026, with an anticipated award date of August 10, 2026. The county expects to process approximately 25,031 tests annually across two collection sites in Plano and McKinney operating Monday through Friday plus five Saturdays per year. Evaluation criteria weight vendor understanding of scope and qualifications equally with cost (30 points each), with client references and optional Phase 2 demonstrations weighted at 15 and up to 30 points respectively. The county retains the right to award in whole or in part to multiple vendors. Funding flows from Texas Department of Criminal Justice appropriations subject to annual availability.